subpart 205.3--synopses
of contract awards
(Revised December 22, 2023)
205.301 General.
205.303 Announcement of contract awards.
205.301 General.
(a)(S-70) Synopsis
of exceptions to domestic source requirements.
(i) In accordance with 10 U.S.C. 4862(k), contracting officers also must synopsize through the Governmentwide point of entry (https://www.sam.gov), awards exceeding the simplified acquisition threshold that are for the acquisition of any clothing, fiber, yarn, or fabric items described in 225.7002-1(a)(1)(ii) through (x), if—
(A) The Secretary concerned has determined that
domestic items are not available, in accordance with 225.7002-2(b); or
(B) The acquisition is for chemical warfare
protective clothing, and the contracting officer has determined that an
exception to domestic source requirements applies because the acquisition furthers
an agreement with a qualifying country, in accordance with 225.7002-2(n).
(ii) The synopsis must be submitted in sufficient
time to permit its publication not later than 7 days after contract award.
(iii) In addition to the information otherwise
required in a synopsis of contract award, the synopsis must include one of the
following statements as applicable:
(A) “The exception at DFARS 225.7002-2(b) applies
to this acquisition, because the Secretary concerned has determined that items
grown, reprocessed, reused, or produced in the United States cannot be acquired
as and when needed in satisfactory quality and sufficient quantity at U.S.
market prices.”
(B) “The exception at DFARS 225.7002-2(n) applies
to this acquisition, because the contracting officer has determined that this
acquisition of chemical warfare protective clothing furthers an agreement with
a qualifying country identified in DFARS 225.003(10).”
205.303 Announcement of contract awards.
(a) Public
Announcement.
(i) The threshold for DoD awards is $7.5 million. Report all contractual actions, including modifications, that have a face value, excluding unexercised options, of more than $7.5 million.
(A) For undefinitized contractual actions, report the not-to-exceed (NTE) amount. Later, if the definitized amount exceeds the NTE amount by more than $7.5
million, report only the amount exceeding the NTE.
(B) For indefinite delivery, time and material, labor hour, and similar contracts, report the initial award if the estimated face value, excluding unexercised
options, is more than $7.5 million. Do not report orders up to the estimated value, but
after the estimated value is reached, report subsequent modifications and orders that
have a face value of more than $7.5 million.
(C) Do not report the same work twice.
(ii) Departments and agencies submit the
information—
(A) To the Office of the Assistant to the Secretary of Defense for Public Affairs;
(B) By the close of business the day before the
date of the proposed award;
(C) Using report control symbol DD-
(D) Including, as a minimum, the following—
(1)
Contract data. Contract number, modification number, or
delivery order number, face value of this action, total cumulative face value
of the contract, description of what is being bought, contract type, whether
any of the buy was for foreign military sales (FMS) and identification of the
FMS customer;
(2) Competition information. Number of solicitations mailed and number
of offers received;
(3) Contractor
data. Name, address, and place of
performance (if significant work is performed at a different location);
(4) Funding
data. Type of appropriation and
fiscal year of the funds, and whether the contract is multiyear (see FAR
Subpart 17.1); and
(5) Miscellaneous
data. Identification of the
contracting office, the contracting office point of contact, known
congressional interest, and the information release date.
(iii) Departments and agencies, in accordance with
department/agency procedures and concurrent with the public announcement, shall
provide information similar to that required by paragraph (a)(ii) of this
section to members of Congress in whose State or district the contractor is
located and the work is to be performed.